Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Incyte Corporation
University of Cincinnati
Medical College of Wisconsin
Fred Hutchinson Cancer Center
Children's Oncology Group
Dana-Farber Cancer Institute